Index of All HIV and AIDS Articles by Topic ( A to Z)
Index of All Hepatitis C Articles by Topic ( A to Z)

Caffeine Linked to Reduced Histological Activity in People with Hepatitis C

By Liz Highleyman

Some recent studies have shown that caffeine consumption is associated with a reduced risk of liver disease progression and elevated serum alanine aminotransferase (ALT) levels. Some researchers have suggested that these effects may be attributable to the antioxidant properties of caffeine.

To evaluate this hypothesis, researchers from Hôpital Henri Mondor in Creteil, France, evaluated the impact of caffeine consumption on histological activity grade and ALT levels in 238 treatment-naive patients with histologically proven chronic hepatitis C. They collected data on patient demographics, route of HCV transmission, HCV genotype, body mass index (BMI), ALT level at the time of liver biopsy, steatosis, histological activity grade, and METAVIR fibrosis stage.

Participants were asked about their daily consumption of alcohol, tobacco, and caffeine during the 6 months preceding liver biopsy. Daily caffeine consumption was estimated by adding the mean intake of coffee, tea, and caffeine-containing soda, and subjects were classified into 4 groups according to caffeine consumption.

Results

Participants included 154 men and 84 women, with a mean age of 45.4 years.

There was a significant inverse relationship between histological activity grade and daily caffeine consumption (P < 0.001).

No relationship was observed between daily caffeine consumption and ALT level.

In a multivariate analysis, caffeine intake greater than 407 mg/day (about 3 cups) predicted a lesser risk of moderate or marked histological activity grade (OR 0.46; P = 0.003).

Other factors independently associated with activity grade were moderate or severe steatosis (OR 3.30; P = 0.004), age greater than 40 years (OR 2.15; P = 0.018), and ALT level (OR 1.02; P < 0.001).

 Daily caffeine consumption
(mg/day)

 Number of subjects

Moderate-marked histological activity grade (A2-A3)
n (%)

< 224

59

45 (77.5)

225-407

57

35 (61.4)

408-679

62

32 (51.6)

>679

60

29 (48.3)

Conclusion

In conclusion, the authors wrote, "caffeine consumption appears to have a positive impact on histological activity in patients with chronic hepatitis C."

11/17/06

Reference
C Hezode, C Costentin, F Roudot-Thoraval, and others. Impact of Caffeine Consumption on Histological Activity in Patients with Chronic Active Hepatitis C. 57th AASLD. Boston, MA. October 27-31, 2006. Abstract 216.



Google_______________


 

 


Conference
Main Page


Hepatitis C
FDA-Approved
Treatments

Monotherapies
Intron A
Roferon
Infergen
Pegasys
PEG-Intron


Combination
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Hepatitis B
FDA-Approved
Treatments

Baraclude
Epivir-HBV
Hepsera
Intron A
Pegasys
Tyzeka